As telehealth models begin to be offered widely by healthcare providers and payors, state regulations that foster or inhibit such models continue to be of interest. POLITICO
recently spoke with Polsinelli’s Cybil Roehrenbeck
about telehealth, state action immunity for antitrust actions, and innovation in health care. Specifically, Cybil commented on the tension between state boards’ antitrust immunity and pressures to regulate new forms of health care delivery, like telehealth.
To read the article, click here